Use of rituximab in NHL malt type pregnant in I° trimester for two times

Autor: Sica Antonello, Vitiello Paola, Papa Alfonso, Calogero Armando, Sagnelli Caterina, Casale Danilo, Mottola Maria, Svanera Gino, Dodaro Concetta Anna, Martinelli Erika, Troiani Teresa, Ciardiello Fortunato, Casale Beniamino
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: Open Medicine, Vol 14, Iss 1, Pp 757-760 (2019)
Druh dokumentu: article
ISSN: 2391-5463
DOI: 10.1515/med-2019-0087
Popis: Administration of rituximab, one of the basic drugs for the therapy of B-cell lymphoproliferative diseases, during pregnancy has been suspected to cause developmental fetal events, particularly if given during the first trimester of pregnancy. Therefore, use in pregnancy is not permitted. Howe ver, several cases of pregnant women being treated with rituximab are reported herein; an exception is often made in cases with grave illness.
Databáze: Directory of Open Access Journals